Joyce Onwuka
The Biolinx Africa, YTO Foundation and Nextgen Molecular Lab have announced a landmark South-South partnership backed by a $3.5 million investment by Equity Bank in Kenya, and the acquisition of a NovaSeq X Plus sequencing platform.
The partners stated that the collaboration will meaningfully expand genomics capacity and bring precision medicine closer to African populations, starting with Kenya and Côte d’Ivoire.
The partnership was unveiled during a closed high-level roundtable titled “From Dialogue to Delivery: Building Africa’s Future in Genomics and Precision Medicine,” convened on the margins of the World Health Summit Regional Meeting 2026 in Nairobi, Kenya.
The session brought together genomics researchers, government regulators, development finance partners, investors and global health organizations to confront the barriers holding back sustainable genomics infrastructure in Africa and to define practical next steps.
The first phase of the collaboration will focus on building sequencing capacity, supporting African led genomic data generation and analysis, and establishing a 24-month implementation roadmap anchored in Kenya and Côte d’Ivoire.
The NovaSeq X Plus platform, which Illumina describes as a production-scale system for large-scale sequencing applications, will be a central pillar of that infrastructure buildout.
Africa holds the greatest human genetic diversity in the world, yet African populations remain significantly underrepresented in global genomic studies and reference databases.
This gap has real clinical consequences, including inaccurate diagnoses, misinterpreted findings, and treatments that are less effective for the populations that need them the most.
At the same time, genomics and precision medicine are gaining stronger policy traction across the continent. AUDA-NEPAD has identified genomics as one of Africa’s scientific priorities; Africa CDC reports that six countries have already launched national genomics strategies, with 11 more having finalized plans pending launch.
In February 2026, the WHO Executive Board adopted a resolution on precision medicine calling for investment in genomics, pharmacogenomics, laboratory infrastructure, genomic databases and bioinformatics.
“Genomics in Africa has to move from conversation to capability. This partnership is about putting infrastructure, investment and African scientific leadership behind a practical delivery agenda.” said Dr. Robert Karanja, Founder and Executive Director, Biolinx Africa
“African populations remain underrepresented in the genomic landscape that increasingly shapes prevention, diagnosis, treatment and research priorities. This partnership is about building local capacity and generating data that are more relevant to African patients and can be applied to improve their health. Better date, better care.” noted Prof. David Tea Okou, Clinical Molecular Geneticist and Founder, YTO Foundation
Commenting Dr. George Michuki, Chief Executive Officer, Nextgen Molecular Lab , said, ‘We are seeing how pharmacogenomics can help explain differences in treatment response and support more personalized cancer care. The next step is to bring these tools closer to routine clinical decision making and, over time, into treatment pathways and coverage discussions.”
The announcement also reflects the power of African scientific networks in catalyzing cross-border collaboration. Dr. Karanja and Prof. Tea Okou are both members of the African Voices of Science (AVoS) cohort, an initiative launched by Speak Up Africa in 2020 to amplify African researchers and health experts and to help shift policy and investment toward African-led health solutions. It was through AVoS that the two leaders first connected — making this partnership a direct product of the network’s convening power.
“When we launched African Voices of Science, we believed that bringing together the right African scientists and giving them a platform to speak with authority would lead to exactly this kind of outcome. The partnership between Biolinx Africa, YTO Foundation and Nextgen Molecular Lab is a powerful demonstration of what happens when we invest in African scientific leadership.” said Fara Ndiaye, Co-Founder and Deputy Director, Speak Up Africa
The partners describe the initiative as a platform for long-term collaboration in genomics and precision medicine, with Kenya and Côte d’Ivoire as the initial anchor countries and an ambition to expand across the continent as infrastructure and partnerships mature